
Opinion|Videos|December 31, 2024
Patient Education and Key Considerations for Initiating Topical JAK Inhibitors
Author(s)Douglas DiRuggiero, DMSc, MHS, PA-C
A panelist discusses how initiating topical JAK inhibitors requires thorough patient education about proper application techniques, safety monitoring, and setting realistic expectations for treatment response timelines.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Hair Transplantation Expands Beyond the Scalp: Eyebrows, Beard, and Beyond
2
FDA Approves Brepocitinib for Dermatomyositis
3
The Aesthetic Edge: August 2026
4
The Multibillion-Dollar Molecule: How Zumilokibart’s Phase 2 Success Sparked AbbVie’s Acquisition
5















